|
The
chase begins
Strategic move or sell out, the Ranbaxy Laboratories-Daiichi
Sankyo deal could mark the beginning of a new era in the Indian
pharmaceutical market. As players realign themselves to their
new role as prey rather than predators, Arshiya Khan and Suja
Nair analyse different options
Troikaa
Pharma—A chariot of success
At 25 years, Troikaa Pharmaceuticals has reached a cutting
edge and is looking at setting up manufacturing facilities
and marketing networks in India and abroad. Manjusha Morgaonkar
traces the company's journey
EMEA
initiatives for SME pharma companies
Micro, small and medium-sized enterprises (SMEs) play a central
role in the pharma industry. They are a major source of entrepreneurial
skills, innovation and employment. However, they are often
confronted with market imperfections. This article gives an
insight into EMEA's plans for SMEs
To
patent or not to patent
One of the main objectives of the patents system-to develop
new knowledge for prosperity of mankind-is getting diluted.
The system is instead helping monopolisation of new knowledge
for exploiting mankind. The need of the hour is to grant patents
in a way that serves public interest
'Our
future plans for India are simple'
Suren Dixit, Director, Operations (Division of Scientific
Products India), Cole-Parmer (CP), shares details of the product
catalogue launched in India with Sachin Jagdale
Millipore
ranked 17th in Globe 100 list
Millipore has climbed to number 17 on the 'Globe 100' list—an
annual ranking of the top 100 publicly held companies in Massachusetts,
published by The Boston Globe newspaper on May 22 this year.
Products
|
